Review Article
Prognostic Value of Long Noncoding RNA SPRY4-IT1 on Survival Outcomes in Human Carcinomas: A Systematic Review and Meta-Analysis with TCGA Database
Table 3
Correlation between lncRNA SPRY4-IT1 expression and clinicopathological parameters for cancers.
| Clinicopathological parameters | No. of studies | Pooled OR (95% CI) | | Model | Heterogeneity | Chi2 | value | |
| Age | 6 | 0.889 (0.626~1.262) | 0.512 | Fixed | 1.38 | 0.926 | 0.00% | Gender | 14 | 0.994 (0.797~1.239) | 0.954 | Fixed | 8.41 | 0.816 | 0.00% | LNM | 13 | 1.982 (1.112~3.534) | 0.020 | Random | 60.55 | <0.001 | 80.20% | DM | 5 | 1.736 (1.193~2.525) | 0.004 | Random | 30.99 | <0.001 | 87.10% | Tumor size | 9 | 2.201 (1.696~2.857) | <0.001 | Fixed | 9.96 | 0.268 | 19.7% |
|
|